Health Trials

Cisplatin

3

Review clinical trials related to Cisplatin. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin

A phase II study evaluating dexamethasone sparing regimen with olanzapine and palonosetron for patients receiving high dose cisplatin to prevent chemotherapy induced nausea and vomiting

Participants needed: 95
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Mahidol UniversityUpdated: Jul 13, 2026Locations: 1
Eligibility criteria

histologically confirmed solid malignancy [+1]

pregnancy [+6]

Read more
Status: Recruiting

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

The Phase IIIb NIAGARA-2 study aims to expand on the data from the Phase III NIAGARA study by investigating perioperative durvalumab in combination with investigator-selected cisplatin-based neoadjuvant chemotherapy (either ddMVAC or gemcitabine/cisplatin) in a clinical practice setting.

Participants needed: 150
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: AstraZenecaUpdated: Jun 11, 2026Locations: 59
Eligibility criteria

Participants with clinical tumour stage T2-T4aN0/1M0 or T1N1M0 with transitional... [+4]

Evidence of lymph node (N2-N3) or metastatic (M1) disease [+5]

Read more
Status: Recruiting

Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

The purpose of this study is to compare cisplatin-based with carboplatin-based chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma (NPC), in order to confirm the value of carboplatin-based chemoradiotherapy in NPC patients.

Participants needed: 482
Trial details
Phase: Phase 3Age: 18-64Biological sex: AllType: InterventionalSponsor: Nanfang Hospital, Southern Medical UniversityUpdated: Jun 18, 2023Locations: 1
Eligibility criteria

Patients with newly histologically confirmed non-keratinizing (according to Worl... [+7]

WHO Type keratinizing squamous cell carcinoma or basaloid squamous cell carcinom... [+7]

Read more